Assessing antimalarial efficacy in a time of change to artemisinin-based combination therapies: the role of Médecins Sans Frontières.
Enregistré dans:
Auteurs principaux: | Jean-Paul Guthmann, Francesco Checchi, Ingrid van den Broek, Suna Balkan, Michel van Herp, Eric Comte, Oscar Bernal, Jean-Marie Kindermans, Sarah Venis, Dominique Legros, Philippe J Guerin |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2008
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a5092d86b19441e9a731a11dae685d0d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Research in complex humanitarian emergencies: the Médecins Sans Frontières/Epicentre experience.
par: Vincent Brown, et autres
Publié: (2008) -
Research ethics review in humanitarian contexts: the experience of the independent ethics review board of Médecins Sans Frontières.
par: Doris Schopper, et autres
Publié: (2009) -
To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?
par: Freek de Haan, et autres
Publié: (2021) - Médecine
-
High-level production of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli.
par: Hiroko Tsuruta, et autres
Publié: (2009)